Ionis and Biogen Win Prestigious Prix Galien Best Biotechnology Product Award for SPINRAZA

CARLSBAD, Calif., Oct. 27, 2017 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that Ionis and Biogen have been awarded the Prix Galien USA Award for the Best Biotechnology Product in 2017 for SPINRAZA® (nusinersen). The Prix Galien USA Award recognizes extraordinary achievement in scientific innovation that improves the state of human health. The award was presented at a ceremony in New York City on October 26, 2017.

The release as fetched from its publisher. ionis.com ↗